A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache

This study is a retrospective chart review in patients diagnosed with headache or migraine to evaluate treatment patterns and diagnosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Migraine Disorders Brain Diseases Central Nervous System Diseases Headache Headache Disorders Headache Disorders, Primary Nervous System Diseases Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Raleigh, North Carolina, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of chronic migraine or other diagnosis of migraine or headache for a minimum of 15 months
Eight (8) headache days per month for at least 1 of the preceding 15 months

Exclusion criteria

Not currently diagnosed with chronic migraine, headache or migraine
History of receiving botulinum toxin injections for the treatment of chronic migraine.

Treatment and study plan

No intervention

Other

There is no intervention in this study.

Primary outcomes

Presence or Absence of Prophylactic Medication for Headache/Migraine

Time frame: 15 Months

The presence or absence of prophylactic medications used by the subject for headache/migraine is evaluated through the study period.

Secondary outcomes

Number of Unique Prophylactic Medications for Headache/Migraine Reported

Time frame: 15 Months

The numbers of unique prophylactic medications used by the subjects for headache/migraine are evaluated through the study period.
Number of Days With a Headache Recorded at the Visit With the Highest Number of Headaches

Time frame: 15 Months

The number of headache days is reported at the visit with the highest number of headaches.
Highest Number of Headache Days Per Month at a Qualifying Visit

Time frame: 15 Months

The highest number of headache days per month are reported at a qualifying visit per the medical record.
Number of Visits for Headache Diagnosis

Time frame: 15 Months

The number of visits for headache diagnosis is evaluated through the study period.

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start: 2014
Primary completion: 2014
Study completion: 2014
First posted: Sep 19, 2013
Registry last updated: Mar 15, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed